Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:41 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
NCT00127101 · Merck Sharp & Dohme LLC · PHASE1 · terminated · last registry update 2015-04-21 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The study was stopped due to low enrollment.” | – | Registry record, Merck Sharp & Dohme LLC |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against HDAC1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2016-03-22Results posted on the registry: National Cancer Institute (NCI), Azacitidine + Lenalidomide (NCT01522976)
- 2016-03-17Results posted on the registry: National Cancer Institute (NCI), Azacitidine + Entinostat (NCT01349959)
- 2016-03-02Results posted on the registry: ECOG-ACRIN Cancer Research Group, Depsipeptide (NCT00104884)
- 2015-11-24Results posted on the registry: National Cancer Institute (NCI), vorinostat + isotretinoin (NCT00324740)
- 2015-10-23Results posted on the registry: Novartis Pharmaceuticals, Panobinostat + Bortezomib (NCT01023308)
- 2015-08-18Results posted on the registry: National Cancer Institute (NCI), Carboplatin + Paclitaxel (NCT01413750)
- 2015-07-02Results posted on the registry: M.D. Anderson Cancer Center, Vorinostat + Azacitidine (NCT00948064)
- 2015-05-19Results posted on the registry: National Cancer Institute (NCI), romidepsin (NCT00084682)
- 2015-05-13Results posted on the registry: National Cancer Institute (NCI), Temozolomide + Vorinostat (NCT00731731)
- 2015-03-10Results posted on the registry: Columbia University, Vorinostat + Niacinamide (NCT00691210)
- 2015-02-06Results posted on the registry: National Cancer Institute (NCI), vorinostat + gemtuzumab ozogamicin (NCT00895934)
- 2014-11-07Results posted on the registry: University of Washington, vorinostat + anastrozole (NCT01153672)
- 2014-11-06Results posted on the registry: University of Washington, vorinostat + anastrozole (NCT01720602)
- 2014-09-08Results posted on the registry: National Cancer Institute (NCI), vorinostat (NCT00262834)
- 2014-07-16Results posted on the registry: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, carboplatin + paclitaxel albumin-stabilized nanoparticle formulation (NCT00616967)
- 2014-04-24Results posted on the registry: University of Maryland, Baltimore, Vorinostat + Lapatinib (NCT01118975)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision